Clinical Trial Update: Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate [Phase 2]

View source ↗

Summary

A Phase 2 study comparing extended-release niacin and fenofibrate in HIV-infected individuals with low HDL assesses effects on endothelial function, lipoprotein…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ER Niacin (extended-release niacin)
• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2014-10-21